GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Labcorp Holdings Inc.
Labcorp is one of two giants in the US medical testing market. Its business is divided into two segments: routine patient testing and more complex clinical research support for pharmaceutical companies. The stock price reflects the balance between these two segments.
Share prices of companies in the market segment - Pharma tests
Labcorp is one of two dominant players in the clinical laboratory testing market. We classify it as part of the Pharmaceutical Testing sector. The chart below reflects the overall dynamics of this stable market, which also includes a large contract research business for pharmaceutical companies.
Broad Market Index - GURU.Markets
Labcorp is a leading global life sciences company providing clinical laboratory research and drug development services. It is a component of the GURU.Markets index. The chart below shows the market. See how Labcorp shares compare to the healthcare sector.
Change in the price of a company, segment, and market as a whole per day
LH - Daily change in the company's share price Labcorp Holdings Inc.
Labcorp is one of the world's largest clinical laboratory operators and contract research organizations. Its daily share price fluctuations reflect its sensitivity to healthcare trends. This metric is an important component of formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma tests
Labcorp Holdings Inc. is a leader in the laboratory diagnostics market. This chart shows the average daily volatility of the healthcare sector. Comparing it with LH's performance helps us understand how sensitive its business, which depends on testing volume and R&D, is to overall trends.
Daily change in the price of a broad market stock, index - GURU.Markets
Labcorp is one of the world's largest clinical laboratory operators. The healthcare sector is considered relatively defensive. The chart below shows general market fluctuations, which can be used to assess Labcorp's response to economic challenges.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Labcorp Holdings Inc.
ะะฐะณััะทะบะฐ...
Annual dynamics of market capitalization of the market segment - Pharma tests
Laboratory Corporation of America Holdings (Labcorp) is one of two giants in the clinical laboratory services and drug development research market. Its scale and wide range of tests create a high barrier to entry. This chart shows how its business is responding to changes in the healthcare system and pharmaceutical companies' R&D spending.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Labcorp is one of the world's largest clinical laboratory research companies. Demand for its diagnostic services is stable and driven by healthcare system needs rather than economic cycles. Labcorp's stock performance reflects long-term trends in medicine, such as personalized diagnostics and an aging population.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Labcorp Holdings Inc.
The market capitalization of Labcorp, a leader in laboratory diagnostics, depends on testing volumes. The monthly fluctuations on the chart reflect both routine demand for medical tests and the cyclical demand for clinical trial services from pharmaceutical companies, which depends on their R&D budgets.
Monthly dynamics of market capitalization of the market segment - Pharma tests
Labcorp is a global leader in laboratory diagnostics and contract research services for pharmaceutical companies. The dynamics of the medical testing sector, presented in the chart, reflect both the volume of routine testing and investment in drug development. This provides a useful context for assessing how Labcorp's diversified business has responded to changes in both these areas.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
The medical laboratory sector is considered defensive, as demand for testing is relatively unaffected by the economy. The chart below shows the general market ebbs and flows. Does Labcorp demonstrate this stability, moving more smoothly than the overall market, especially during downturns?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Labcorp Holdings Inc.
Labcorp, one of the largest clinical laboratory operators in the world, whose weekly stock price reflects trends in healthcare. Routine and specialized test volumes, news about the development of new diagnostic methods, and changes in reimbursement policies drive short-term fluctuations.
Weekly dynamics of market capitalization of the market segment - Pharma tests
Labcorp, a leader in laboratory diagnostics, is a barometer for its healthcare segment. This chart compares the company's stock performance with the industry, demonstrating how it is influenced by overall trends in medical testing volumes, which impact all market players.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Labcorp is one of the world's largest medical laboratory operators. Demand for diagnostic tests is consistent and unaffected by economic cycles. The chart shows that Labcorp shares act as a safe haven, demonstrating stability amid overall market volatility.
Market capitalization of the company, segment and market as a whole
LH - Market capitalization of the company Labcorp Holdings Inc.
Labcorp's chart is a financial snapshot of the American healthcare system. The market capitalization of one of the largest clinical laboratory operators reflects the volume of medical tests and analyses performed. Its dynamics are not only an indicator of current disease incidence but also a bet on the future of preventive medicine and drug development.
LH - Share of the company's market capitalization Labcorp Holdings Inc. within the market segment - Pharma tests
Labcorp (Laboratory Corporation of America) is one of the world's largest companies in clinical laboratory research and diagnostics. Its share of the sector's market capitalization reflects its enormous scale and central role in the healthcare system. The chart below shows how much of the medical testing market this giant controls.
Market capitalization of the market segment - Pharma tests
Labcorp is one of two giants in the clinical laboratory testing market. The chart below shows the overall market capitalization of the entire healthcare sector. Its dynamics reflect the growing demand for diagnostics, drug development, and an aging population.
Market capitalization of all companies included in a broad market index - GURU.Markets
Labcorp is a global leader in laboratory diagnostics. Its market capitalization chart is a financial reflection of the importance of testing in modern medicine. It demonstrates the enormous share of the healthcare economy occupied by businesses providing critical data to doctors and patients.
Book value capitalization of the company, segment and market as a whole
LH - Book value capitalization of the company Labcorp Holdings Inc.
Labcorp is a laboratory diagnostics giant. Its book value is derived from a global network of laboratories equipped with sophisticated equipment. The chart below shows how the company is investing in expanding and modernizing this infrastructure to process millions of tests daily.
LH - Share of the company's book capitalization Labcorp Holdings Inc. within the market segment - Pharma tests
Labcorp is a leader in laboratory diagnostics. Its business is impossible without a vast network of high-tech laboratories and patient service centers. The asset share chart shows the scale of this physical infrastructure, which forms the basis for conducting millions of tests.
Market segment balance sheet capitalization - Pharma tests
The healthcare sector, as the graph shows, has a vast material base. Labcorp, as a leader in diagnostics, is a vital part of this. Its business is capital-intensive, requiring a network of hundreds of laboratories and thousands of collection pointsโthe physical infrastructure for testing.
Book value of all companies included in the broad market index - GURU.Markets
Labcorp is a pillar of the American healthcare system. The company's assets include a vast network of laboratories across the country, where millions of tests are processed daily. The chart below illustrates the physical scale of this diagnostics giant within the medical infrastructure.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Labcorp Holdings Inc.
Labcorp Holdings Inc. is one of the two largest companies in the laboratory diagnostics industry. The premium placed on its assets (laboratories) reflects its scale, its indispensable role in the healthcare system, and its ability to generate stable cash flow.
Market to book capitalization ratio in a market segment - Pharma tests
Labcorp Holdings Inc. is one of the largest clinical laboratory operators in the world. Its value lies in its network scale, data volume, and testing technologies. This chart shows how investors value its position in the healthcare market beyond the value of its laboratories and equipment, and how this compares to its competitors.
Market to book capitalization ratio for the market as a whole
Labcorp (Laboratory Corporation of America) is one of the world's largest companies in medical testing and clinical research. Its value lies not only in its laboratories and equipment, but also in its vast database, extensive network of test collection points, and reputation. The chart shows how the market values โโthese competitive advantages in the key healthcare sector.
Debts of the company, segment and market as a whole
LH - Company debts Labcorp Holdings Inc.
Labcorp, a leader in laboratory diagnostics and clinical research, uses debt to invest in new testing technologies and make strategic acquisitions. The company acquires specialized laboratories and technology firms to expand its services. This chart shows how innovations in medical diagnostics are financed.
Market segment debts - Pharma tests
Labcorp is one of the world's largest clinical laboratory research and diagnostics companies. Its business requires constant investment in new equipment, technology, and acquisitions of smaller laboratories. This chart shows how Labcorp's debt policy reflects its strategy to maintain leadership in the rapidly growing healthcare services and diagnostics sector.
Market debt in general
Labcorp Holdings Inc. is a global leader in laboratory diagnostics and contract research for pharmaceutical companies. The healthcare sector is stable but requires investment in technology. This chart helps evaluate how Labcorp is leveraging its financial leverage to expand its services and make acquisitions to remain at the forefront of medical science.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Labcorp Holdings Inc.
Labcorp, a leader in clinical laboratory research, continually invests in new testing technologies and diagnostic equipment. This chart shows how the company finances its innovations and acquisitions. Debt levels reflect its growth strategy in the rapidly evolving healthcare sector.
Market segment debt to market segment book capitalization - Pharma tests
Labcorp Holdings is a global leader in laboratory diagnostics. This chart shows the debt burden in the medical testing sector. It helps understand how companies in this vital part of healthcare finance their research, lab automation, and acquisitions, and how Labcorp competes in this dynamic market.
Debt to book value of all companies in the market
Labcorp is a leader in laboratory diagnostics. This chart reflects the overall leverage of corporate America. It allows one to assess how aggressively Labcorp is using capital for acquisitions and innovation, given the overall economic situation and the availability of financing in the market.
P/E of the company, segment and market as a whole
P/E - Labcorp Holdings Inc.
This chart of Labcorp Holdings shows the valuation of one of the world's largest clinical laboratory operators and drug development partners. The company's profits are driven by the volume of medical tests and pharmaceutical research activity. This metric reflects investor expectations regarding future demand for diagnostics and R&D outsourcing.
P/E of the market segment - Pharma tests
Labcorp Holdings is a leading global life sciences company, providing clinical laboratory research and drug development services. The company plays a key role in diagnostics and pharmaceutical innovation. This chart illustrates the average valuation in the medical testing and research sector, where scale, precision, and innovation are essential.
P/E of the market as a whole
Labcorp Holdings is one of the world's largest medical research companies, providing services ranging from routine blood tests to complex clinical trials. This chart reflects overall market sentiment. Comparisons with it help understand whether Labcorp is perceived as a stable player in the healthcare sector, unaffected by economic cycles.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Labcorp Holdings Inc.
Labcorp (Laboratory Corporation of America) is one of the world's leading life sciences companies, providing clinical laboratory testing and diagnostic services. This graph reflects expectations for healthcare development. The assessment depends on the volume of medical testing and pharmaceutical companies' investments in drug development.
%20P%2FE%20Labcorp%20Holdings%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Labcorp-Holdings-Inc.&v=1772616539886 "Chart of the company's future (projected) P/E Labcorp Holdings Inc.")
Future (projected) P/E of the market segment - Pharma tests
Labcorp is a leading global life sciences company providing clinical laboratory research and drug development services. The chart shows how analysts estimate Labcorp's future profitability relative to the broader industry. This provides insight into whether the market views their integrated diagnostics and research model as promising for growth.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-tests&v=1772616539899 "Future (projected) P/E graph of the market segment - Pharma tests")
Future (projected) P/E of the market as a whole
Labcorp Holdings is one of the world's leading laboratory diagnostics companies. Its business consists of routine testing and clinical research support. This trend in overall market expectations impacts the latter part of its business. Growing optimism is spurring biotech companies to invest in R&D, increasing demand for Labcorp's services.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772616539904 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Labcorp Holdings Inc.
Labcorp is one of the world's largest clinical laboratory operators. The company performs a wide range of medical tests for physicians, hospitals, and pharmaceutical companies. Its revenue depends on the volume of tests performed and the development of drug development. This chart reflects the state of the healthcare system and investments in new medical technologies.
Profit of companies in the market segment - Pharma tests
Labcorp is one of the largest clinical laboratory operators in the world. Demand for its diagnostic services is stable and growing alongside an aging population and advances in medicine. The chart below demonstrates how medical services companies form a resilient and non-cyclical segment of healthcare, providing a stable share of overall industry revenue.
Overall market profit
Labcorp (Laboratory Corporation of America) is one of the world's leading companies in medical testing and clinical research. Demand for diagnostic services is constant, and the drug development segment relies on investment in R&D. This combination ensures Labcorp's resilience throughout the economic cycle, as reflected in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Labcorp Holdings Inc.
Labcorp is one of the largest clinical laboratory operators in the world, providing a wide range of diagnostic tests. This chart shows future revenue expectations. Analysts' forecasts depend on the volume of routine and specialized testing, insurance rates, and the performance of the company's drug development division (Covance).
%20profit%20of%20the%20company%20Labcorp%20Holdings%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Labcorp-Holdings-Inc.&v=1772616539998 "Graph of future (projected) profit of the company Labcorp Holdings Inc.")
Future (predicted) profit of companies in the market segment - Pharma tests
Labcorp Holdings is a leading global life sciences company providing clinical laboratory research and drug development services. This chart shows the revenue forecast for the entire pharmaceutical testing sector. It reflects expectations for diagnostic demand and R&D spending in the pharmaceutical industry, which drive both Labcorp business segments.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-tests&v=1772616540028 "Graph of future (predicted) profits of companies in a market segment - Pharma tests")
Future (predicted) profit of the market as a whole
Labcorp Holdings is a leading company in clinical laboratory services and drug development. Demand for its diagnostic tests depends on the number of physician visits, while its drug development business depends on the R&D budgets of pharmaceutical companies. The overall economic environment, reflected here, influences both segments through insurance company policies and investments in biotechnology.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772616540061 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Labcorp Holdings Inc.
Labcorp (Laboratory Corporation of America) is one of the two largest clinical laboratory research companies in the world. It is also a major player in contract research for pharmaceutical companies. This chart shows how the market values โโits revenue, which is influenced by overall healthcare spending and investment in drug development.
P/S market segment - Pharma tests
Labcorp (Laboratory Corporation of America) is one of the world's largest clinical laboratory research and diagnostics companies. It plays a key role in the healthcare system. This chart reflects the average revenue estimate for the sector, helping to understand how the market perceives Labcorp's scale and role in diagnostics and drug development.
P/S of the market as a whole
Labcorp (Laboratory Corporation of America) is one of the world's largest clinical laboratory operators, providing diagnostic testing and drug development services. It is a vital part of the healthcare system. This overall market valuation chart allows you to compare how investors value the stable revenues in the healthcare sector against more cyclical industries.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Labcorp Holdings Inc.
Labcorp is one of the world's leading companies in medical diagnostic services and drug development. Future revenue depends on the volume of tests conducted and outsourcing contracts with pharmaceutical companies. This chart shows how investors assess the growth in demand for diagnostics and R&D in the healthcare sector.
%20P%2FS%20Labcorp%20Holdings%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Labcorp-Holdings-Inc.&v=1772616540125 "The graph of the company's future (projected) P/S Labcorp Holdings Inc.")
Future (projected) P/S of the market segment - Pharma tests
Labcorp Holdings is a leading global life sciences company providing clinical laboratory diagnostics and drug development services. Its business benefits from an aging population and growing medical innovation. This chart shows how the market values โโits future revenue, reflecting its key role in the healthcare ecosystem.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20tests&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-tests&v=1772616540144 "Future (projected) P/S market segment graph - Pharma tests")
Future (projected) P/S of the market as a whole
Labcorp is one of the world's largest clinical laboratory research companies. Demand for its services is stable but also depends on developments in the pharmaceutical industry. The optimism shown in this chart indicates investors' confidence in new drugs and treatments. Labcorp plays a key role in conducting analyses for clinical trials of these innovations.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772616540145 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Labcorp Holdings Inc.
Labcorp is a global leader in medical laboratory services. The company's revenue consists of diagnostic testing for patients and clinical research support services for pharmaceutical companies. The chart below shows total revenue, reflecting demand for medical diagnostics and drug development activity.
Sales of companies in the market segment - Pharma tests
Labcorp is one of the world's leading providers of medical laboratory services. The company's business is divided into two segments: diagnostics (routine and specialized testing) and drug development (clinical trial services for pharmaceutical companies). This chart reflects growth in both healthcare and pharmaceutical innovation, where Labcorp plays a key role.
Overall market sales
Labcorp (Laboratory Corporation of America) is one of the world's largest companies in medical testing and clinical research. Demand for diagnostic tests is stable, but the clinical research sector depends on pharmaceutical companies' investment in R&D. This graph, reflecting economic health, influences the pharmaceutical sector's willingness to invest in new drug development.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Labcorp Holdings Inc.
Labcorp (Laboratory Corporation of America) is one of the world's largest companies in clinical laboratory research and diagnostics. Its revenue depends on the volume of medical testing and drug development. This chart shows analysts' expectations for growth in demand for diagnostic services and clinical trial activity.
%20sales%20of%20the%20company%20Labcorp%20Holdings%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Labcorp-Holdings-Inc.&v=1772616540202 "Schedule of future (projected) sales of the company Labcorp Holdings Inc.")
Future (projected) sales of companies in the market segment - Pharma tests
Labcorp is a leading global life sciences company providing clinical laboratory research and drug development services. This chart provides a forecast for the pharmaceutical services sector. It helps assess how synergies between its diagnostics and research divisions enable Labcorp to serve the entire healthcare value chain.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-tests&v=1772616540219 "Schedule of future (projected) sales of companies in the market segment - Pharma tests")
Future (projected) sales of the market as a whole
Labcorp Holdings, a leader in clinical laboratory research, sees this chart as a reflection of the state of the healthcare system. Rising overall economic forecasts ensure stable funding for healthcare services. This allows doctors to prescribe more diagnostic tests, and pharmaceutical companies to conduct clinical trials, the core of Labcorp's business.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772616540279 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Labcorp Holdings Inc.
Labcorp (Laboratory Corporation of America) is one of the world's largest clinical laboratory testing companies. They provide medical testing for hospitals, physicians, and pharmaceutical companies. This chart illustrates how their massive scale and efficiency in processing millions of tests enable them to achieve consistent profitability in the healthcare sector.
Market segment marginality - Pharma tests
Labcorp is one of the world's leading providers of medical laboratory services, from routine blood tests to complex diagnostics. This chart shows the company's profitability. Its ability to maintain above-industry-average profitability reflects its scale, process automation, and broad range of tests offered to physicians and hospitals.
Market marginality as a whole
Labcorp is one of the world's leading companies in medical diagnostic services and clinical research. Demand for its services is driven by demographic trends and healthcare system needs, rather than short-term economic fluctuations. This chart allows us to assess the resilience of the healthcare sector relative to overall market dynamics.
Employees in the company, segment and market as a whole
Number of employees in the company Labcorp Holdings Inc.
Labcorp Holdings is one of the largest clinical laboratory operators in the world. This chart directly reflects medical testing volumes. The increase in the number of phlebotomists, lab technicians, and logistics personnel is a direct result of the increased demand for diagnostic services, both from physicians and as part of large-scale programs, such as during the pandemic.
Share of the company's employees Labcorp Holdings Inc. within the market segment - Pharma tests
Labcorp (Laboratory Corporation of America) is one of the world's leading life sciences companies, providing services from diagnostics to drug development. This chart shows its workforce in the healthcare sector. It reflects the significant proportion of laboratory technicians, scientists, and clinical research specialists that Labcorp employs.
Number of employees in the market segment - Pharma tests
Labcorp Holdings is one of the world's leading life sciences companies, providing clinical laboratory research and drug development services. The chart illustrates the scale of employment in the healthcare sector. The vast number of laboratory technicians, scientists, and physicians reflects Labcorp's key role in diagnosing diseases and advancing new treatments.
Number of employees in the market as a whole
Labcorp Holdings is one of the world's leading companies in medical laboratory diagnostics and clinical research. This overall employment pattern impacts both segments of its business. The growing number of insured workers is driving demand for routine testing. At the same time, a healthy economy is stimulating pharmaceutical companies to invest in new research, such as that conducted by Labcorp.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Labcorp Holdings Inc. (LH)
Labcorp is one of the world's leading life sciences companies, providing diagnostics and clinical research services. This chart shows a business that combines scale and science. Its moderate capitalization per employee reflects the presence of both thousands of lab technicians and highly skilled scientists, creating value at multiple levels.
%20of%20the%20company%20Labcorp%20Holdings%20Inc.%20(LH)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Labcorp-Holdings-Inc.-LH&v=1772616540569 "Chart of market capitalization per employee (in thousands of dollars) of the company Labcorp Holdings Inc. (LH)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma tests
Labcorp (LH) is one of two dominant companies in the laboratory testing industry. It's a high-volume service business, requiring a network of laboratories and a large staff of technicians. This chart shows the market price per employee in this high-volume medical industry.
%20by%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-tests&v=1772616540602 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma tests")
Market capitalization per employee (in thousands of dollars) for the overall market
Labcorp is a global leader in medical testing and laboratory diagnostics. Its value lies in its scale and vast volume of data. This chart shows the market value generated by each employee, from lab technician to scientist, processing millions of samples and providing critical information to doctors and patients.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772616540639 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Labcorp Holdings Inc. (LH)
Labcorp (Laboratory Corporation of America) is one of the two largest clinical laboratory networks in the US (along with Quest). They are also a major contract research organization (CRO). This chart shows how efficiently the company manages its high-tech laboratories and clinical trial personnel. It is an indicator of automation and margins in the testing business.
%20Chart%20Labcorp%20Holdings%20Inc.%20(LH)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Labcorp-Holdings-Inc.-LH&v=1772616540661 "Company Profit Per Employee (in thousands of dollars) Chart Labcorp Holdings Inc. (LH)")
Profit per employee (in thousands of dollars) in the market segment - Pharma tests
Labcorp (LH) is one of two giants (along with Quest) in the laboratory diagnostics (testing) space. This chart shows the benchmark for Pharma testing (Diagnostics). In this sector, staff profitability is an indicator of automation. It's a "testing factory." The benchmark shows how efficiently the sector processes millions of test tubes.
%20in%20the%20market%20segment%20-%20Pharma%20tests&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-tests&v=1772616540752 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma tests")
Profit per employee (in thousands of dollars) for the market as a whole
Labcorp is one of the world's largest medical research companies, providing services from routine testing to complex clinical trials. It's a business that requires both scale and scientific expertise. This chart reflects how effectively the company combines mass testing and cutting-edge research to achieve profitability.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772616540801 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Labcorp Holdings Inc. (LH)
Labcorp is a leading global life sciences company providing clinical laboratory research and drug development services. This chart shows its performance in the healthcare sector. The increase in revenue per employee reflects test automation and increased demand for their services from physicians and pharmaceutical companies.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Labcorp-Holdings-Inc.-LH&v=1772616540834 "Sales chart per company employee Labcorp Holdings Inc. (LH)")
Sales per employee in the market segment - Pharma tests
Labcorp is one of two dominant companies in the US clinical laboratory testing market. It's a labor-intensive business, requiring the management of thousands of labs and technicians. This chart shows the industry average revenue per employee. It helps evaluate how productive their large laboratory network is compared to Quest.
Sales per employee for the market as a whole
Labcorp is one of two giants in the laboratory diagnostics industry. They perform billions of tests (blood tests, etc.) for doctors and hospitals. They are also a major CRO (clinical trial support company). This chart shows how efficiently their automated labs and team of scientists generate revenue.
Short shares by company, segment and market as a whole
Shares shorted by company Labcorp Holdings Inc. (LH)
Labcorp is one of the two largest companies in the US (along with Quest) providing clinical laboratory testing services. This chart shows bets on a decline. Bears are shorting LH, pointing to a sharp drop in COVID-19 testing revenue. Furthermore, the sector is suffering from pricing pressure from insurance companies, which are constantly lowering testing rates.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Labcorp-Holdings-Inc.-LH&v=1772616541126 "Short Shares Chart for the Company Labcorp Holdings Inc. (LH)")
Shares shorted by market segment - Pharma tests
Labcorp (LH) is one of two giants in the US clinical laboratory services market, also involved in R&D (clinical trials) for pharmaceutical companies. This chart shows bets against the healthcare sector. Rising bets against the industry may reflect investor concerns about a decline in routine testing volumes (due to the recession) or pressure from insurers on test prices.
Shares shorted by the overall market
Labcorp is one of the largest clinical laboratory networks. Their services are always in demand, making the business relatively defensive. However, this indicator reflects the level of general fear. When panic mounts in the market, it can even affect the healthcare sector, especially if investors fear a recession will lead to a reduction in elective (non-emergency) testing.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Labcorp Holdings Inc. (LH)
Labcorp is one of two giants in the clinical testing market. Their business is the volume of tests ordered by doctors. This oscillator measures momentum. A severe flu season or the launch of a new popular test (for example, in oncology) could trigger a rally (above 70). Meanwhile, news of Medicare rate cuts (putting downward pressure on prices) would push it below 30.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Labcorp-Holdings-Inc.-LH&v=1772616541261 "RSI 14 indicator chart for the company's stock Labcorp Holdings Inc. (LH)")
RSI 14 Market Segment - Pharma tests
Labcorp is one of the world's leading providers of medical diagnostic services and drug discovery solutions (CROs). They perform billions of tests and support clinical trials. This metric reflects the overall health of the medical diagnostics industry, helping determine whether the entire sector is oversold after the pandemic boom or is experiencing steady growth.
RSI 14 for the overall market
Labcorp (LH) is a global leader in laboratory diagnostics and research for pharmaceutical companies. It is a key part of the healthcare system. This chart reflects the overall market climate. In times of panic, investors often look for "defensive" sectors, and healthcare, including diagnostics (LH), is one such sector, thanks to its stable demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast LH (Labcorp Holdings Inc.)
Labcorp (Laboratory Corporation of America) is one of two giants in the US clinical laboratory testing market. The company is also a major contract researcher (CRO) for pharmaceutical companies. This chart reflects analyst forecasts for basic testing volumes (non-Covid-related) and R&D spending in the biotech sector.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-LH-Labcorp-Holdings-Inc.&v=1772616541436 "A chart showing analyst consensus forecasts for the expected stock price. LH (Labcorp Holdings Inc.)")
The difference between the consensus estimate and the actual stock price LH (Labcorp Holdings Inc.)
Labcorp is one of two dominant players in the US clinical laboratory services market. They provide blood and other tests for physicians and hospitals. They are also a major CRO (supporting clinical drug trials). This chart shows analyst estimates for their testing volumes (non-COVID) and R&D business. It reflects the gap between their target price and their current price.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-LH-Labcorp-Holdings-Inc.&v=1772616541463 "A chart showing the difference between the consensus forecast and the actual stock price. LH (Labcorp Holdings Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma tests
Labcorp is one of two giants (along with Quest) in the US medical testing and laboratory services market. The company also assists with R&D for pharmaceutical companies. This chart shows analysts' overall expectations for the pharmaceutical testing sector. It reflects whether experts expect demand for diagnostics to grow or decline following the pandemic boom.
Analysts' consensus forecast for the overall market share price
Labcorp (LH) is a global leader in laboratory diagnostics. From routine blood tests to complex genetic testing for pharmaceutical companies, their business spans the entire healthcare system. This chart shows the overall market sentiment, reflecting analysts' overall confidence in the stability of healthcare spending.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Labcorp Holdings Inc.
Labcorp is one of two giants (along with Quest Diagnostics) in the US clinical laboratory services market. They perform billions of tests annually. They recently spun off their drug development business (Fortrea). This graph reflects the underlying demand for medical services. Its dynamics depend on the volume of routine and specialized tests ordered by physicians and hospitals.
AKIMA Market Segment Index - Pharma tests
Labcorp is one of the two (along with Quest) giants in the diagnostics world; the company operates a vast network of laboratories (blood testing, etc.) and is also a major CRO (clinical trials). This composite metric evaluates companies. The chart shows the sector average. This is a benchmark: how does Labcorp's dual (diagnostics + CRO) model differentiate it from the average competitor?
The AKIM Index for the overall market
Labcorp is one of two giants (along with Quest) in the clinical laboratory testing industry. The company is also a major clinical trial operator (CRO). This chart, reflecting the market average, provides context. It helps assess how Labcorp, a defense business dependent on testing volumes and pharmaceutical R&D budgets, fits within the overall macroeconomic picture.
